Erdheim-Chester disease with chorioretinal and orbital involvement: a case report
2022

Case Report of Erdheim-Chester Disease with Eye Involvement

Sample size: 1 publication Evidence: low

Author Information

Author(s): Cabuk Kubra Serefoglu, Tellioglu Adem, Karabulut Gamze Ozturk, Nacaroglu Senay Asik, Fazil Korhan, Elverdi Tuğrul, Taskapili Muhittin, Karslioglu Safak

Primary Institution: University of Health Sciences Beyoglu Eye Training and Research Hospital, Istanbul, Turkey

Conclusion

The patient with Erdheim-Chester disease showed improvement with interferon-alpha treatment but experienced vision loss after stopping the therapy.

Supporting Evidence

  • The patient presented with bilateral proptosis, chemosis, leg pain, and vision loss.
  • Interferon-alpha-2a was started, leading to initial improvement in her condition.
  • Vision loss occurred after the patient stopped the interferon treatment.

Takeaway

A woman had a rare disease that affected her eyes and needed special medicine to help her see better, but she stopped taking the medicine and lost some of her vision again.

Methodology

The case was diagnosed based on clinical, radiological, and pathological findings, and treatment was administered with interferon-alpha-2a.

Limitations

The patient discontinued follow-up and treatment, which may have affected the outcomes.

Participant Demographics

A 42-year-old Moldovian female patient.

Digital Object Identifier (DOI)

10.5935/0004-2749.2022-0151

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication